Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year review.
about
Biological agents in gastrointestinal cancers: adverse effects and their management.A spectrum of cutaneous toxicities from erlotinib may be a robust clinical marker for non-small-cell lung therapy: a case report and literature reviewRitonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer.Ocular side effects of biological agents in oncology: what should the clinician be aware of?Class act: safety comparison of approved tyrosine kinase inhibitors for non-small-cell lung carcinoma.Biology of the eyelash hair follicle: an enigma in plain sight.Ocular Toxicity of Tyrosine Kinase Inhibitors.Ocular toxicities of MEK inhibitors and other targeted therapies.EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model.Erlotinib induced ectropion following papulopustular rash.Use of amniotic membrane graft in the surgical management of cicatricial ectropion associated with cetuximab therapy.Bilateral acute simultaneous onset anterior uveitis presumed secondary to erlotinib: A report of two cases.Patient-reported symptoms and stepwise symptom management in patients on epidermal growth factor inhibitors: A retrospective, descriptive cohort study.Erlotinib-related keratopathy in a patient underwent laser in situ keratomileusis.
P2860
Q33895581-DD531701-4918-47F6-88CB-08F48A8AC454Q35541916-CB535071-0F21-459D-93AD-6335C0777D10Q37193103-CB89D64D-A381-4756-AB1A-7176F55C6B79Q37427522-3705B8DD-A645-43BF-A53A-E4D29AC40914Q38262804-59BD9139-5CFE-4641-BB5E-C7CB9519A703Q38603091-76B1B91A-FBF0-4697-8356-F63B9C3675F6Q38746683-6C0CB0D2-5893-4B23-9490-FD98899184C4Q38764273-E93DA34B-70C6-4B91-8DF0-510E532047E9Q38932568-03F302C2-F482-425A-A6DE-ED89FB649B81Q42400314-14495371-622E-4398-A116-875DD67B4DAFQ43097330-E472984D-FE31-49D5-A0FE-B1D35E3EAD74Q47096237-6678008B-7E6E-4DB5-BBB8-F7C023CA0881Q48287408-EE0A74BD-9DEE-48E5-A3A1-63C08F275590Q54248299-057D9C10-8175-41B8-AA72-CFB8D88C1AD6
P2860
Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year review.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Spectrum of ocular toxicities ...... follow-up: a five-year review.
@en
type
label
Spectrum of ocular toxicities ...... follow-up: a five-year review.
@en
prefLabel
Spectrum of ocular toxicities ...... follow-up: a five-year review.
@en
P2860
P1476
Spectrum of ocular toxicities ...... follow-up: a five-year review
@en
P2093
Durga S Borkar
Surendra Basti
P2860
P2888
P304
P356
10.1007/S00520-012-1645-Y
P577
2012-11-15T00:00:00Z